» Articles » PMID: 16736026

Trends in the Incidence of Primary Liver and Biliary Tract Cancers in England and Wales 1971-2001

Overview
Journal Br J Cancer
Specialty Oncology
Date 2006 Jun 1
PMID 16736026
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

In the last two decades, mortality from primary liver cancer has increased in the UK. We aimed to determine whether the incidence trends for these cancers were similar and in particular if the increasing occurrence of cholangiocarcinoma has continued. We calculated directly age-standardised incidence rates (using the European standard population) by subsite and histological type for all cancers of the liver, gallbladder and biliary tract in England and Wales from 1971 to 2001, using cancer registry data. The incidence of cancers of the liver, gallbladder and biliary tract increased, with the greatest rise, around 12-fold, in intrahepatic bile duct cancers. The rate of liver cell cancer increased by around 45% in males, but by <10% in females. There were marked reductions in the incidence of gallbladder and extrahepatic bile duct cancer. Cholangiocarcinoma increased around 16-fold and became the most common type of primary liver cancer in females, while hepatocellular carcinoma remained the commonest type in males. The age-specific incidence rates showed that intrahepatic bile duct cancer continued to increase throughout the 1990s in those aged 75 and over, while liver cell cancer decreased in the older age groups. In conclusion, there were increases in the incidence of primary liver cancer, which have been particularly dramatic for intrahepatic bile duct cancer, over the last three decades of the 20th century in England and Wales. There has been a halving in the incidence of gallbladder cancer and a reduction of a third in extrahepatic bile duct cancer.

Citing Articles

Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping review.

Mysko C, Landi S, Purssell H, Allen A, Prince M, Lindsay G BJC Rep. 2025; 3(1):13.

PMID: 40033086 PMC: 11876667. DOI: 10.1038/s44276-025-00126-5.


Survival disparities among racial groups with hepatic malignant tumors.

Han D, Zhang Z, Deng J, Du H World J Gastrointest Oncol. 2024; 16(7):2999-3010.

PMID: 39072178 PMC: 11271794. DOI: 10.4251/wjgo.v16.i7.2999.


The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma.

Esmail A, Badheeb M, Alnahar B, Almiqlash B, Sakr Y, Al-Najjar E Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065760 PMC: 11279608. DOI: 10.3390/ph17070910.


Interpretable machine learning-based clinical prediction model for predicting lymph node metastasis in patients with intrahepatic cholangiocarcinoma.

Xie H, Hong T, Liu W, Jia X, Wang L, Zhang H BMC Gastroenterol. 2024; 24(1):137.

PMID: 38641789 PMC: 11031954. DOI: 10.1186/s12876-024-03223-w.


Recent Advances in Systemic Therapy for Advanced Intrahepatic Cholangiocarcinoma.

Yoo C, Hyung J, Chan S Liver Cancer. 2024; 13(2):119-135.

PMID: 38638168 PMC: 11023692. DOI: 10.1159/000531458.


References
1.
Brock A, Griffiths C, Rooney C . The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales. Health Stat Q. 2005; (23):7-17. View

2.
Patel T . Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001; 33(6):1353-7. DOI: 10.1053/jhep.2001.25087. View

3.
Shaib Y, El-Serag H, Davila J, Morgan R, McGlynn K . Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005; 128(3):620-6. DOI: 10.1053/j.gastro.2004.12.048. View

4.
El-Serag H, Mason A . Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999; 340(10):745-50. DOI: 10.1056/NEJM199903113401001. View

5.
Davila J, Morgan R, Shaib Y, McGlynn K, El-Serag H . Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 2005; 54(4):533-9. PMC: 1774454. DOI: 10.1136/gut.2004.052167. View